Consolidated Statements of Cash Flow (Unaudited)	3 Months Ended
	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)
Cash flows from operating activities
Net loss including non controlling interest	$ (48,452,344)	$ (4,066,996)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	480,349	367,538
Stock based compensation	26,230,989
Deferred income taxes	(37,185)	(26,005)
Unrealised foreign exchange loss/(profit)	(3,398)	11,413
Fair value losses in financial instruments carried at fair value	17,152,060
Expected credit loss (net of reversal)	(50,682)
Balances written off/(back)		(32,778)
Changes in assets and liabilities, net of assets acquired and liabilities assumed from acquisitions:
Inventories	(6,803)	(18,928)
Income taxes, net		19,362
Accounts receivables, net	1,037,883	(2,851,128)
Prepayments and other assets	1,046,454	(1,339,900)
Accounts payable and accrued expenses and other current liabilities	(2,767,021)	7,951,537
Other liabilities	(296,982)	(2,937,334)
Net cash used in operating activities	(5,666,680)	(2,923,219)
Cash flows from investing activities
Sale/ (Purchase) of property and equipment, intangible assets and goodwill	32,745	204,329
Acquisition of businesses		(2,720,000)
Proceeds from sale of mutual fund	193,606
Proceeds from forward purchase agreement	1,000,000
Net cash used in investing activities	1,226,351	(2,515,671)
Cash flows from financing activities
Proceeds from issue of preferred stock		4,445,027
Proceeds from long-term borrowings		2,662,590
Repayments of long-term borrowings	(121,365)	(29,622)
Net proceeds/(payments) from short-term borrowings	1,154,519	5,298,782
Net cash generated from financing activities	1,033,154	12,376,777
Effect of exchange rate changes on cash and cash equivalents	(3,519)	(31,815)
Net (decrease)/increase in cash and cash equivalents (including restricted cash)	(3,410,694)	6,906,072
Cash acquired in business combination		11,180,117
Cash and cash equivalents at the beginning of the period (including restricted cash)	11,565,088	1,131,831
Cash and cash equivalents at the end of the period (including restricted cash)	8,154,394	19,218,020
Reconciliation of cash and cash equivalents
Cash and cash equivalents	7,777,413	18,674,424
Restricted cash	376,981	543,596
Total cash and cash equivalents	8,154,394	19,218,020
Supplemental disclosure of cash flow information
Cash paid for interest, net of amounts capitalized	391,829	123,180
Cash paid for income taxes, net of refunds		84,197
Non-cash investing and financing activities
Consideration payable in connection with acquisitions	488,000	3,621,531
Interest accrued on borrowings	$ 790,395	$ 143,278